Floatz logo

Clozapine

Cannabis Abuse

Dartmouth-Hitchcock Medical CenterSmall moleculePhase 4 / ApprovedDormant
BB
70/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
55/ 100
Competitive Position
95/ 100

Competitive context

9 Active assets in the Cannabis Abuse cohort.

View all 15

Same molecule, other indications

Clozapine is also rated in:

Psychotic DisorderDormant
BBB
Indicative ·
78 / 100
View asset →
Dual DiagnosisDormant
BB
Indicative ·
70 / 100
View asset →
schizophreniaDormant
BB
Indicative ·
70 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →